Skip to main content

  • Lytic No Better Than Aspirin for Mild Ischemic Stroke

    But early termination of randomized PRISM trial made findings not definitive

    Functional outcomes were just as good with aspirin as with thrombolytic alteplase (Activase) for mild, non-disabling acute ischemic stroke in the PRISMS trial, although its early termination might have undermined the conclusions.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details